Debra S Brandt - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Affective Disorders|November 3, 2024

Depression in the time of COVID-19: Examination of prenatal and postpartum depression, rurality, and the impact of COVID-19Kelsey L Blocklinger, Serena B Gumusoglu, Ashlyn S Kenney, et al.

AJPM Focus|October 4, 2023

Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for ImprovementDonna A Santillan, Alexander J Hubb, Taryn E Nishimura, et al.

Breast Cancer Research and Treatment|February 4, 2018

Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancerJulia Foldi, Sarah Mougalian, Andrea Silber, et al.

Journal of Clinical and Translational Science|June 20, 2022

Barriers and solutions to developing and maintaining research networks during a pandemic: An example from the iELEVATE perinatal networkDonna A Santillan, Debra S Brandt, Rachel Sinkey, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Affective Disorders|November 3, 2024

Depression in the time of COVID-19: Examination of prenatal and postpartum depression, rurality, and the impact of COVID-19Kelsey L Blocklinger, Serena B Gumusoglu, Ashlyn S Kenney, et al.

AJPM Focus|October 4, 2023

Group B Streptococcus Screening and Treatment Adherence in Pregnancy: A Retrospective Cohort Study and Opportunities for ImprovementDonna A Santillan, Alexander J Hubb, Taryn E Nishimura, et al.

Breast Cancer Research and Treatment|February 4, 2018

Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I-III HER2-positive breast cancerJulia Foldi, Sarah Mougalian, Andrea Silber, et al.

Journal of Clinical and Translational Science|June 20, 2022

Barriers and solutions to developing and maintaining research networks during a pandemic: An example from the iELEVATE perinatal networkDonna A Santillan, Debra S Brandt, Rachel Sinkey, et al.

Pageof 2